Characteristics of fatty acid distribution is associated with colorectal cancer prognosis

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 5, 2013, Pages 355-360

  Zhang, Junjie ^a   Zhang, Lijian ^a   Ye, Xiaoxia ^a   Chen, Liyu ^a   Zhang, Liangtao ^a   Gao, Yihua ^a   Kang, Jing X ^b   Cai, Chun ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Colorectal cancer; Fatty acid; Gas chromatography; Mass spectrometry

Indexed keywords

ACYL COENZYME A DESATURASE; ARACHIDONIC ACID; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; STEARIC ACID;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID ANALYSIS; FATTY ACID OXIDATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; RECTUM MUCOSA;

AGED; ARACHIDONIC ACID; COLON; COLORECTAL NEOPLASMS; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INTESTINAL MUCOSA; LINOLEIC ACID; MALE; MIDDLE AGED; PROGNOSIS; RECTUM;

EID: 84877620358     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.02.005     Document Type: Article

References (45)

1. Parkin D.M., et al. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55(2):74-108.
2. Colditz G.A., Sellers T.A., Trapido E. Epidemiology-identifying the causes and preventability of cancer?. Nat. Rev. Cancer 2006, 6(1):75-83.
3. Crowe F.L., et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 2008, 88(5):1353-1363.
4. Zerouga M., et al. Phospholipid class as a determinant in docosahexaenoic acid's effect on tumor cell viability. Anticancer Res. 1996, 16(5A):2863-2868.
5. S. Basiouni, et al., Polyunsaturated fatty acid supplements modulate mast cell membrane microdomain composition, Cell. Immunol 275 (1-2) (2012) 42-46.
6. de Pablo M.A., de Cienfuegos G.Alvarez Modulatory effects of dietary lipids on immune system functions. Immunol. Cell. Biol. 2000, 78(1):31-39.
7. Grimble R.F., Tappia P.S. Modulatory influence of unsaturated fatty acids on the biology of tumour necrosis factor-alpha. Biochem. Soc. Trans. 1995, 23(2):282-287.
8. Jolly C.A., et al. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J. Nutr. 1997, 127(1):37-43.
9. Arab L. Biomarkers of fat and fatty acid intake. J. Nutr. 2003, 133(Suppl 3):925S-932S.
10. DeBerardinis R.J., et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7(1):11-20.
11. Menendez J.A., Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 2007, 7(10):763-777.
12. Chow C.K. Fatty acid composition of plasma phospholipids and risk of prostate cancer. Am. J. Clin. Nutr. 2009, 89(6):1946. author reply 1946-7.
13. Chajes V., et al. Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int. J. Cancer 1999, 83(5):585-590.
14. Petrek J.A., et al. Fatty acid composition of adipose tissue, an indication of dietary fatty acids, and breast cancer prognosis. J. Clin. Oncol. 1997, 15(4):1377-1384.
15. London S.J., et al. Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J. Natl. Cancer Inst. 1993, 85(10):785-793.
16. McNamara R.K., et al. Gender differences in rat erythrocyte and brain docosahexaenoic acid composition: role of ovarian hormones and dietary omega-3 fatty acid composition. Psychoneuroendocrinology 2009, 34(4):532-539.
17. Stark K.D., Park E.J., Holub B.J. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy. Menopause 2003, 10(5):448-455.
18. Al-Tamer Y.Y., Mahmood A.A. Lipid components and fatty acid composition of Iraqi subjects who smoke and consume dairy products. Nutr. Metab. Cardiovasc. Dis. 2004, 14(2):94-96.
19. Pawlosky R.J., Salem N. Perspectives on alcohol consumption: liver polyunsaturated fatty acids and essential fatty acid metabolism. Alcohol 2004, 34(1):27-33.
20. Kang J.X., Wang J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem. 2005, 6:5.
21. Ford J.H. Saturated fatty acid metabolism is key link between cell division. cancer, and senescence in cellular and whole organism aging, Age (Dordr) 2010, (2):231-237.
22. Worman C.P., Barker W.R., Apostolov K. Saturation index of blood cell membrane fatty acids before and after IFN treatment in hairy cell leukemia. Leukemia 1987, 1(4):379-382.
23. Kositsawat J., et al. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer. J. Urol. 2007, 178(6):2391-2396. Discussion 2396.
24. Zaridze D.G., et al. Fatty acid composition of phospholipids in erythrocyte membranes and risk of breast cancer. Int. J. Cancer 1990, 45(5):807-810.
25. Thomas B.S., O'Dea J., Fentiman I.S. Erythrocyte membrane stearic and oleic acid ratios in breast cancer. Br. J. Surg. 1988, 75(11):1078-1079.
26. Wang D., Dubois R.N. Eicosanoids and cancer. Nat. Rev. Cancer 2010, 10(3):181-193.
27. Z. Cvetkovic, et al., Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma, Ann. Hematol. 89 (8) (2010) 775-782.
28. Brochot A., et al. Effects of alpha-linolenic acid vs. docosahexaenoic acid supply on the distribution of fatty acids among the rat cardiac subcellular membranes after a short- or long-term dietary exposure. Nutr. Metab. (Lond) 2009, 6(1):14.
29. B.P. Ander, et al., Distribution of omega-3 fatty acids in tissues of rabbits fed a flaxseed-supplemented diet, Metabolism 59 (5) 620-627.
30. Shannon J., et al. Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am. J. Clin. Nutr. 2007, 85(4):1090-1097.
31. Giros A., et al. Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic. Cancer Prev. Res. (Phila) 2009, 2(8):732-742.
32. Spencer L., et al. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur. J. Cancer 2009, 45(12):2077-2086.
33. Tjonneland A., et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009, 58(12):1606-1611.
34. Habbel P., et al. Docosahexaenoic acid suppresses arachidonic acid-induced proliferation of LS-174T human colon carcinoma cells. World J. Gastroenterol. 2009, 15(9):1079-1084.
35. A.J. Cockbain, G.J. Toogood, M.A. Hull, Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer, Gut 61 (1) (2012) 135-149.
36. Huang Y.S., et al. Modification of liver fatty acid metabolism in mice by n-3 and n-6 delta 6-desaturase substrates and products. Biochim. Biophys. Acta 1991, 1082(3):319-327.
37. W. Smink, et al., Linoleic and alpha-linolenic acid as precursor and inhibitor for the synthesis of long-chain polyunsaturated fatty acids in liver and brain of growing pigs, Animal 6 (2) (2012) 262-270.
38. Reyes n., et al. Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Lett. 2004, 209(1):25-35.
39. de Castro J., et al. Platelet linoleic acid is a potential biomarker of advanced non-small cell lung cancer. Exp. Mol. Pathol. 2009, 87(3):226-233.
40. P.L. Nguyen, et al., Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival, J. Clin. Oncol. 28 (25) 3958-3964.
41. Menendez J.A., et al. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin. Chem. 2009, 55(3):425-438.
42. H. Orita, et al., High levels of fatty acid synthase expression in esophageal cancers represent a potential target for therapy, Cancer Biol. Ther. 10 (6) (2010) 549-554.
43. Menendez J.A., et al. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann. Oncol. 2005, 16(3):359-371.
44. Castellone M.D., et al. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005, 310(5753):1504-1510.
45. G. Hawcroft, et al., Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells, Neoplasia 12 (8) (2010) 618-627.